The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
These dynamics can cause headaches for even the most seasoned professionals, which is why we started StockStory - to help you separate the good companies from the bad. That said, here is one stock under $50 with huge potential and two best left ignored.
Two stocks under $50 to sell:
F.N.B. Corporation (FNB)
Share price: $17.79
Tracing its roots back to 1864 during the Civil War era, F.N.B. Corporation (NYSE: FNB) is a diversified financial services holding company that provides banking, wealth management, and insurance services to consumers and businesses across seven states and Washington, D.C.
Why Is FNB Not Exciting?
- Sales trends were unexciting over the last two years as its 6.3% annual growth was below the typical banking company
- Muted 9.9% annual net interest income growth over the last five years shows its demand lagged behind its banking peers
- Earnings growth underperformed the sector average over the last five years as its EPS grew by just 7.4% annually
F.N.B. Corporation is trading at $17.79 per share, or 0.9x forward P/B. Check out our free in-depth research report to learn more about why FNB doesn’t pass our bar.
Phibro Animal Health (PAHC)
Share price: $35.24
With a portfolio of approximately 800 product lines serving farmers and veterinarians in 90 countries, Phibro Animal Health (NASDAQ: PAHC) develops, manufactures, and markets health products for livestock and companion animals, including antibacterials, vaccines, nutritional supplements, and mineral additives.
Why Are We Cautious About PAHC?
- Modest revenue base of $1.54 billion gives it less fixed cost leverage and fewer distribution channels than larger companies
- Estimated sales growth of 2.9% for the next 12 months implies demand will slow from its two-year trend
- Low free cash flow margin of 1.1% for the last five years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders
Phibro Animal Health’s stock price of $35.24 implies a valuation ratio of 11.2x forward P/E. Read our free research report to see why you should think twice about including PAHC in your portfolio.
One stock under $50 to buy:
LSI (LYTS)
Share price: $17.81
Enhancing commercial environments, LSI (NASDAQ: LYTS) provides lighting and display solutions for businesses and retailers.
Why Are We Bullish on LYTS?
- Market share has increased this cycle as its 25.1% annual revenue growth over the last two years was exceptional
- Expected revenue growth of 17.6% for the next year suggests its market share will rise
- Incremental sales significantly boosted profitability as its annual earnings per share growth of 25.8% over the last five years outstripped its revenue performance
At $17.81 per share, LSI trades at 14.9x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Stocks we like even more
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.
